has nothing to do with that. Biotech analysts very split on the new aducanumab data.
has everything to do with sleepy market finding out about first study to propose a MANF mechanism and demonstrate effectiveness in a-syn PD model from a top 10 medical university in China.
I know, I know Japers. We're gonna specialize in selling worm farms and call it, "I got Worms"
has nothing to do with that. Biotech analysts very split on the new aducanumab data.
has everything to do with sleepy market finding out about first study to propose a MANF mechanism and demonstrate effectiveness in a-syn PD model from a top 10 medical university in China.